Gallacher Capital Management LLC
Source: SEC Form 13F · as of Mar 2026Gallacher Capital Management LLC holds 22 biotech & pharma companies tracked by BioSniper, totaling $9.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
22
Total value held
$9.1M
| Company | Shares | Value |
|---|---|---|
| NVSNovartis AG | 6,273 | $958K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 16,183 | $893K |
| AZNASTRAZENECA PLC | 4,043 | $797K |
| JNJJOHNSON & JOHNSON | 2,457 | $601K |
| GMABGenmab A/S | 21,797 | $585K |
| LLYELI LILLY & Co | 624 | $574K |
| HALOHALOZYME THERAPEUTICS, INC. | 8,614 | $557K |
| TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | 24,520 | $454K |
| IDXXIDEXX LABORATORIES INC /DE | 660 | $371K |
| ARGXARGENX SE | 490 | $358K |
| HRMYHarmony Biosciences Holdings, Inc. | 12,669 | $355K |
| AMGNAMGEN INC | 1,007 | $354K |
| SNYSanofi | 7,253 | $349K |
| NVONovo Nordisk A/S | 9,100 | $334K |
| MEDPMedpace Holdings Inc. | 583 | $280K |
| ALKSAlkermes plc. | 7,677 | $271K |
| ABBVAbbVie Inc. | 1,091 | $237K |
| NBIXNEUROCRINE BIOSCIENCES INC | 1,758 | $232K |
| INCYIncyte Corp. | 2,457 | $231K |
| PTCTPTC THERAPEUTICS, INC. | 3,019 | $206K |
| FLNAFilana Therapeutics Inc. | 64,972 | $110K |
| ANVSAnnovis Bio, Inc. | 15,705 | $35K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.